CRISPR/Cas9 VS ES Targeting:Which is the optimal solution?
With the rapid advancement of biomedical technology in recent years, customized treatment methods such as targeted medicine, immunotherapy, and gene therapy have become the main directions of biomedical innovation - which is intimately related to the development of gene-editing technology. From the ongoing CRISPR patent battles, to the approval of the FDA on the clinical trial of human gene editing by Editas, the continued development of gene-editing technology is highly anticipated. Modern animal model gene-editing technology can be divided into two main categories: embryonic stem cell (ESC) targeting and CRISPR/Cas9 editing technology. Custom genetic model types include transgenic, knockout (KO), conditional knockin (cKI), humanization, and point mutations. Given the unique advantages offered between CRISPR/Cas9 gene editing or ESC mediated gene targeting, which is the optimal solution? How can you...